ADIPOQ and metabolic syndrome: Although leptin levels were not different among the groups, the leptin/adiponectin ratio, which has been shown to be a predictor of metabolic syndrome (47) and insulin resistance (48), was significantly increased in the TBI group and trending upward in the ABM group (Figure 6C).